GENTEAL MILD LIQUID DROPS - hypromellose liquid 
Novartis Pharmaceuticals Corporation

----------

Drug Facts

Active ingredient

hypromellose (0.2%)

Purpose

Lubricant

Uses

Warnings

Do not use if solution changes color or becomes cloudy.

When using this product do not touch tip of container to ant surface. Replace cap after using.

Stop use and ask a doctor if you experience any of the following:

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Put 1 or two drops in the affected eye(s) as needed.

Other Information

Store between 15⁰- 30⁰C (59⁰86⁰F)

Questions? call toll-free 1-866-393-6336, weekdays, 8:30 AM - 5:00 PM EST.

Serious side effects associated with use of this product may be reported to this number.

Inactive ingredients

Boric acid, calcium chloride dihydrate, sodium perborate, phosphonic acid, potassium chloride, purified water, sodium chloride


PRINCIPAL DISPLAY PANEL

PRODUCT PACKAGING

The product packaging shown below represents a sample of that currently in use. Additional packaging may also be available.


GenTeal

Mild Liquid Drops

Lubricant Eye Drops

Dry Eye Relief

Fast, Soothing Relief

Preservative Free in the Eye

USE ONLY IF TAMPER EVIDENT SEAL MARKED NOVARTIS IS INTACT.

GenTeal Mild Liquid Drops


GENTEAL  MILD LIQUID DROPS
hypromellose   liquid
Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)0078-0517
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYPROMELLOSE (HYPROMELLOSE) HYPROMELLOSE0.002 L  in 1 L
Inactive Ingredients
Ingredient NameStrength
ADEFOVIR 
BORIC ACID 
CALCIUM CHLORIDE 
POTASSIUM CHLORIDE 
SODIUM CHLORIDE 
SODIUM PERBORATE 
WATER 
Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#NDCPackage DescriptionMultilevel Packaging
10078-0517-240.015 L In 1 BOTTLE, DROPPERNone
20078-0517-160.025 L In 1 BOTTLE, DROPPERNone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34909/14/2009

Labeler - Novartis Pharmaceuticals Corporation (002147023)
Revised: 09/2009Novartis Pharmaceuticals Corporation